3D Printed Implants Market growing at a CAGR of 7.5% during the forecast period (2022-2029).

3D Printed Implants Market size was valued at US$ YY billion in 2020 and is estimated to reach US$ YY billion by 2028, growing at a CAGR of 7.5% during the forecast period (2022-2029).

Implantable medical devices printed in 3D. Implantable medical devices made from 3D printing are used in numerous sections of the human body. Vascular stents, heart valve prostheses, orthopaedic implants, and artificial joint prostheses are examples of common items.

The global 3D printed implants market is driven by many factors, such as technological advancement and increased use of 3D printed implants in surgical procedures.

The technological advancement in this market is estimated to drive the global 3D printed implants market

3D printing technology, because of its advantages in high accuracy, complex structure, and high material usage, has become widely used in the field of implantable medical devices in recent decades. Patient-specific anatomical level products with great flexibility and resolution in microstructures are possible with three-dimensional (3D) printing. 3D printing has become a leading Orthopaedic and pharmaceutical manufacturing technology, with cost-effective manufacturing for high productivity. It is apt for a wide range of applications, including tissue engineering models, anatomical models, pharmacological design and validation models, medical apparatus and instruments. Today, 3D printing provides clinically viable medical items and platforms ideal for new research domains such as tissue and organ printing.

For example, on February 17, 2021, the design and print complicated implants for domestic and international markets, the Apollo Hospitals Group has partnered with Anatomiz3D Medtech Pvt Ltd. To begin, 3D-printing facilities for 3D printed implants will be established in several Apollo Hospitals, allowing clinicians to visualise and manufacture implants for difficult patients. In 2021, VESTAKEEP Care M40 3DF, a novel 3D-printable PEEK biomaterial created by Evonik Industries AG for medical applications requiring up to 30 days of body contact. Extrusion-based 3D printing processes like fused filament fabrication and fused deposition modelling can prepare the high-performance polymer.

The increased use of 3D printed implants in surgical procedures is assumed to drive the global 3D printed implants market

Advances in 3D printing technology, such as a wider selection of filament materials and improved precision, indicate that this manufacturing method will be used more frequently for medical implants. Advances in materials 3D printing, which were made as recently as 2020, have resulted in significant progress in the medical industry. Nitinol may be 3D printed, according to studies conducted by the Australian government's scientific research organisation CSIRO last year, permitting mass manufacture of artery stents for circulation disorders. Because of its shape memory qualities, nitinol, titanium, and nickel alloy are attractive for peripheral artery disease (PAD). Fat deposits in the arteries of the legs or arms create PAD, which reduces blood flow to the limbs.

Stents implanted in these damaged arteries must be able to deform while maintaining their shape while the user movements their limbs. As a result, Nitinol is a good material to use for making these stents. Nitinol stents may now be 3D manufactured, according to a CSIRO study. This represents significant progress in additive manufacturing metallurgy (nitinol is rarely used in 3D printing) and an improvement in the geometry of these stents. The intricate mesh design of these 3D-printed stents allows them to expand and compress more efficiently than regular stents. Prosthetic medicine isn't the only branch of medicine that necessitates a high level of personalization. Patient-specific gadgets (such as hearing aids) and implants (prosthetic joints, cranial plates, and even heart valves) are increasingly turning to 3D printing because of their ease of customization and speed of production.
Traditionally, heart valves and hearing aids required a full week of rigorous, hand-crafted adjustments by expert workers. From casting to fitting, a hearing aid requires nine steps before 3D printing. Hearing aids may now be scanned in 3D and printed in one day. 3D printing can provide complex, porous surfaces for implants like titanium prosthetic joints or cranial plates, making them less likely to be rejected by patients' bodies.
Chinese company Meditool has designed and developed its hardware and software. The programme can read and interpret images straight from magnetic resonance imaging (MRI) and computed tomography scan (CT) devices routinely utilised. The software creates a 3D model that is easily printable and sends it to the printer PEEK, a high-performance polymer supplied by Evonik, is used to 3D print the implants (PEEK). Arterial stents can be made to the user's specifications and manufactured quickly. Rapid production also means that the product is more widely available.

The high-cost and stringent FDA approval's is estimated to hamper the global 3D printed implants market

3D printed implants improve surgical efficiency, recuperation time, and patient quality of life, but all of this comes at a hefty expense. 3D printing, in comparison to traditional implants, uses a variety of resources and sophisticated machines, making it highly advanced yet pricey technology. There is a lot of pricey 3D modelling software which are utilised in for manufacturing 3D printed implants. Simulations and interactive anatomical representations benefit greatly from the use of 3D modelling tools. They're also a terrific way for doctors and patients to gain a better image of a condition. Mimics, Stratasys Ltdatics, Magic, Quant AM, and NX Siemens are examples of FDA-approved software used by 3D Incredible. Other software options include Within Medical, 3DS Max, Ossa 3D, 3D-Doctor, and others. This software is costly, and it requires FDA approval before it can be used by any Orthopaedic company.
Renishaw AM 400, Sindoh 3DWOX 1, CraftUnique Craftbot PLUS, and other 3D printing machines are quite expensive and need a significant initial commitment. Because most 3D printed implants cannot be mass-produced, machine run time increases, increasing infrastructure operating costs. Apart from that, operating a 3D printer necessitates a high level of maintenance and highly skilled personnel; all these aspects are estimated to hamper the market.

COVID-19 Impact Analysis

COVID-19 has affected the healthcare industry negatively. To stop its spread, government-imposed lockdown. People are fearful they may experience occupational effects and negative health from the COVID-19 pandemic. The supply of the raw materials for the manufacturing of the implants and most of the surgical procedures has halted due to COVID-19. This has affected the global 3D printed implants market as many have stopped manufacturing units.

Market Segmentation

• By Implantation Technology
o Electron beam melting technology
o Laser Beam Melting
o Droplet Deposition
o Laminated Deposition
o Other
• By Application
o Orthopaedic
o Dental
o Cranio-maxillofacial
• By End-User
o Medical And Surgical Centers
o Pharmaceutical Companies
o Biotechnology Industry
o Medical Institution
• By Region
o North America
o Latin America
o Europe
o Asia Pacific
o Middle East and Africa

Competitive Landscape

Major key players in the global 3D printed implants market are 3D Systems Corporations, Stratasys Ltd, Arcam AB, EnvisionTEC, SLM Solutions Group AG, Renishaw, Materialize N. V., BioBots, Andreas Stihl AG & Co. KG, Aspect Biosystems, Formlabs, Medprin, Stratasys, Organovo, Rokit, Cyfuse Biomedical and LimaCorporate S.p.A., (Lima)

The global 3D printed implants market is moderate due to the technological advancements in 3D printing and the increasing demand for customized products.

Lima Corporate

Overview: LimaCorporate is a multinational medical device firm that helps surgeons improve their patients' quality of life by delivering reconstructive and fixation orthopaedic solutions.
The company is based in Italy and is dedicated to creating revolutionary products and techniques that allow surgeons to choose the best solutions for each patient. The company's mission is to provide cutting-edge technologies to help orthopaedic surgeons reclaim their patients' Emotion of Motion.

Product Portfolio: The company comprises orthopaedics, medical devices, orthopaedics and medical supplies. LimaCorporate's product line includes primary and revision implants for major joints and comprehensive extremity treatments with fixation.

Key Development: LimaCorporate S.p.A. (Lima) and Hospital for Special Surgery (HSS) have joined forces to build the first provider-based design and 3D printing facility for custom complex joint replacement solutions. The new, FDA-regulated commercial facility, known as the ProMade PoC (Point of Care) and will provide faster and more accessible care for U.S. patients requiring personalised solutions for their orthopaedic conditions, as well as influence the advancement of these complex orthopaedic solutions globally.

Related Topics:

Dental Implants Market - https://www.datamintelligence.com/research-report/dental-implants-market

Medical Implants Market - https://www.datamintelligence.com/research-report/medical-implants-market

Industry Verticals - https://www.datamintelligence.com/category/industry-verticals/medical-devices

DATAM INTELLIGENCE 4MARKET RESEARCH LLP
HABSIGUDA, IDA - UPPAL

About Us:

DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year, we have secured more than 100 unique customers from established organizations all over the world.

We monitor and analyse the market by dissecting various market influencers, competitive intensity, innovations, trends, and emerging products. This aids us in providing a detailed scenario of the present and future of the market.

Contact Us:

Sai Kiran
DataM Intelligence 4Market Research LLP
+1 877-441-4866
info@datamintelligence.com

This release was published on openPR.